SL
TAK icon

Salomon & Ludwin’s Takeda Pharmaceutical TAK Stock Holding History

Salomon & Ludwin’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.6K Buy
2,591
+1,459
+129% +$25.6K ﹤0.01% 492
2025
Q4 		$17.8K Sell
1,132
-27
-2% -$386 ﹤0.01% 997
2025
Q3 		$16.9K Buy
1,159
+1,118
+2,727% +$16.6K ﹤0.01% 944
2025
Q2 		$632 Buy
+41
New +$606 ﹤0.01% 809

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Salomon & Ludwin's TAK Position: Q1 2026 in Review

Salomon & Ludwin increased its Takeda Pharmaceutical (TAK) stake by 129% in Q1 2026, buying an estimated $25.6K and bringing the position to 2,591 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Salomon & Ludwin first reported a position in TAK in Q2 2025 and has held it in 4 quarters since. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Salomon & Ludwin held 2,591 shares of Takeda Pharmaceutical worth $48.6K as of Q1 2026.
  • Salomon & Ludwin bought 1,459 Takeda Pharmaceutical shares in Q1 2026, an estimated $25.6K.
  • Takeda Pharmaceutical made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #492 holding.
  • Salomon & Ludwin first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 4 quarters since.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.